LV-EF1a-tTA-IRES-Puro

What it means: EF1a is the human elongation factor 1 alpha promoter, a strong constitutive cellular promoter that resists silencing and gives stable long-term expression in a wide range of cell types, including stem cells and primary cells.

Why it matters:

• The promoter sets where and how strongly the cassette is expressed after transduction.
• EF1a is generally preferred over viral promoters when sustained expression is needed.
• Promoter choice also affects how quickly expression appears and whether it persists after weeks in culture or in vivo.

How to interpret here: in LV-EF1a-tTA-IRES-Puro, EF1a constitutively expresses the tTA transactivator; the regulated step happens on the partner responder construct, not here.

Tip: when comparing constructs, keep the promoter constant — differences between EF1a and another promoter can be larger than the effect of the transgene itself.

What it means: tTA is the tetracycline transactivator of the Tet-Off system; it activates TRE promoters in the absence of doxycycline.

Why it matters:

• tTA is the regulatory transactivator of the Tet-Off system; on its own it produces no reporter or effector signal.
• A separate responder construct is required: a TRE-driven responder vector; the responder is on without doxycycline and off when doxycycline is added.
• Delivering the regulator by lentivirus lets one stable line be reused with different responder constructs.

How to interpret here: this vector supplies tTA only, expressed constitutively from the EF1a promoter; the switchable step happens on the responder.

Tip: establish and verify the tTA line first, then introduce the responder — debugging both halves at once is the usual reason a Tet-Off experiment fails.

What it means: Inducible (Tet-Off component) — this vector supplies the tTA transactivator component of the Tet-Off system, expressed constitutively.

Why it matters:

• It must be paired with a TRE-driven responder vector; expression of the responder is on in the absence of doxycycline and switched off when doxycycline is added, and nothing on this vector is itself doxycycline-regulated.
• This vector is one half of the system: tTA is expressed constitutively here and the regulated cassette lives on the responder.
• Buying or building the matching responder construct is therefore part of the experiment, not an optional extra.

How to interpret here: LV-EF1a-tTA-IRES-Puro is the tTA component of the Tet-Off system; nothing on this vector is itself switchable.

Tip: verify tTA function with a known responder reporter before committing to the full experiment.

What it means: Puromycin — puromycin N-acetyltransferase (pac) confers resistance to puromycin.

Why it matters:

• Puromycin kills non-transduced mammalian cells quickly, typically within a few days, so stable pools can be selected rapidly.
• The marker decides whether stable pools can be drug-selected and which other markers can be combined in the same cells.
• Selection also removes the untransduced fraction, which simplifies downstream assays that require a uniform population.

How to interpret here: the selection marker for this vector is Puromycin; drug-resistant survivors are the cells that carry the integrated cassette.

Tip: titrate Puromycin on the target cells first (kill curve) — the effective dose varies widely between cell types.

What it means: >1E+9 TU/mL is the functional titer in transducing units (TU) per mL — the number of particles that actually deliver and express the cassette, not the physical particle count.

Why it matters:

• Functional titer is what determines the multiplicity of infection (MOI) you can reach with a given volume.
• The value is stated as a minimum (>1E+9 TU/mL), so treat it as a floor when planning volumes rather than as an exact content figure.
• Functional titers are assay-dependent, so compare titers between vendors only when the titration method is the same.

How to interpret here: calculate MOI from >1E+9 TU/mL and your cell number; optimize MOI per cell type, since transduction efficiency differs between lines and primary cells.

Tip: keep the vector cold during dilution and avoid vortexing — titer loss from repeated freeze-thaw or rough handling is the most common reason a >1E+9 TU/mL stock underperforms.

What it means: BSL-2 is the biosafety containment level required for handling this lentiviral vector.

Why it matters:

• BSL-2 work requires a certified biosafety cabinet, appropriate PPE and decontamination of all waste and surfaces.
• Institutional biosafety approval is usually required before lentiviral work begins, and transfer between labs follows the same containment rules.
• Transduced cells and used media remain BSL-2 material until decontaminated.

How to interpret here: handle LV-EF1a-tTA-IRES-Puro under BSL-2 practices throughout storage, thawing, transduction and disposal.

Tip: check whether your institution requires enhanced BSL-2 practices for lentiviral vectors carrying particular transgenes; this varies between institutions.